Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 2/2006

01-06-2006 | European Congress for Pathology Symposium: Criteria for Malignancy in Endocrine Tumors

Assessment of malignancy in adrenal cortical tumors

Author: Anne Marie McNicol, MD, FRCPATH

Published in: Endocrine Pathology | Issue 2/2006

Login to get access
Metadata
Title
Assessment of malignancy in adrenal cortical tumors
Author
Anne Marie McNicol, MD, FRCPATH
Publication date
01-06-2006
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 2/2006
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:17:2:131

Other articles of this Issue 2/2006

Endocrine Pathology 2/2006 Go to the issue

European Congress for Pathology Symposium: Criteria for Malignancy in Endocrine Tumors

Diagnostic criteria in well-differentiated thyroid carcinomas

Clinical Research

Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series

Letter

Genetic analysis of high altitude paragangliomas

Review

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma

Clinical Research

Diversity of ACTH-immunoreactive cells in the human adenohypophysis: An immunohistochemical study with special reference to cluster formation and follicular cell association

European Congress for Pathology Symposium: Criteria for Malignancy in Endocrine Tumors

Criteria for malignancy in gastrointestinal endocrine tumors
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits